114 related articles for article (PubMed ID: 21595304)
1. [Amorphous form in pharmaceutical technological research].
Mártha C; Jójártné LO; Szabóné RP
Acta Pharm Hung; 2011; 81(1):37-42. PubMed ID: 21595304
[TBL] [Abstract][Full Text] [Related]
2. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
3. Moringa coagulant as a stabilizer for amorphous solids: Part I.
Bhende S; Jadhav N
AAPS PharmSciTech; 2012 Jun; 13(2):400-10. PubMed ID: 22359158
[TBL] [Abstract][Full Text] [Related]
4. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
5. Glass-forming ability of compounds in marketed amorphous drug products.
Wyttenbach N; Kuentz M
Eur J Pharm Biopharm; 2017 Mar; 112():204-208. PubMed ID: 27903457
[TBL] [Abstract][Full Text] [Related]
6. Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development.
Mahlin D; Ponnambalam S; Höckerfelt MH; Bergström CA
Mol Pharm; 2011 Apr; 8(2):498-506. PubMed ID: 21344945
[TBL] [Abstract][Full Text] [Related]
7. Early drug development predictions of glass-forming ability and physical stability of drugs.
Mahlin D; Bergström CA
Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
[TBL] [Abstract][Full Text] [Related]
8. Thermal behavior and molecular mobility studies in the supercooled liquid and glassy states of carvedilol and loratadine.
Viciosa MT; Moura Ramos JJ; Diogo HP
Int J Pharm; 2020 Jun; 584():119410. PubMed ID: 32445909
[TBL] [Abstract][Full Text] [Related]
9. Determination of pKa values of nonsteroidal antiinflammatory drug-oxicams by RP-HPLC and their analysis in pharmaceutical dosage forms.
Demiralay EC; Alsancak G; Ozkan SA
J Sep Sci; 2009 Sep; 32(17):2928-36. PubMed ID: 19662642
[TBL] [Abstract][Full Text] [Related]
10. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
11. Computational predictions of glass-forming ability and crystallization tendency of drug molecules.
Alhalaweh A; Alzghoul A; Kaialy W; Mahlin D; Bergström CA
Mol Pharm; 2014 Sep; 11(9):3123-32. PubMed ID: 25014125
[TBL] [Abstract][Full Text] [Related]
12. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
[TBL] [Abstract][Full Text] [Related]
13. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic behavior of glassy state of structurally related compounds.
Kaushal AM; Bansal AK
Eur J Pharm Biopharm; 2008 Aug; 69(3):1067-76. PubMed ID: 18420396
[TBL] [Abstract][Full Text] [Related]
15. Determination of the glass properties of D-mannitol using sorbitol as an impurity.
Yu L; Mishra DS; Rigsbee DR
J Pharm Sci; 1998 Jun; 87(6):774-7. PubMed ID: 9607958
[TBL] [Abstract][Full Text] [Related]
16. Commentary: Considerations in the Measurement of Glass Transition Temperatures of Pharmaceutical Amorphous Solids.
Newman A; Zografi G
AAPS PharmSciTech; 2019 Dec; 21(1):26. PubMed ID: 31848763
[TBL] [Abstract][Full Text] [Related]
17. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
Soares FL; Carneiro RL
J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
[TBL] [Abstract][Full Text] [Related]
20. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.
Haddadin R; Qian F; Desikan S; Hussain M; Smith RL
Pharm Dev Technol; 2009; 14(1):18-26. PubMed ID: 18825543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
